The high prevalence of extensive and ultra-rapid CYP2C19 metabolizers in the Saudi population suggests potential for decreased efficacy of drugs metabolized by this pathway, such as clopidogrel.
No takes yet. Share an insight, caveat, or question.
May reduce clopidogrel efficacy in Saudis; leaves open population-specific outcome trials before practice change.
Saeed et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: